e-Zassi

e-Zassi is a specialized software-as-a-service (SaaS) provider that offers an open innovation platform tailored for the life sciences, pharmaceutical, and medical device sectors. The company's technology enables organizations to manage the entire lifecycle of external innovation, from initial scouting and submission intake to rigorous evaluation and partnership management. A core feature of the platform is its ability to facilitate blinded reviews of intellectual property, allowing companies to assess external technologies without the risk of contamination from non-confidential disclosures. By streamlining the collaboration between internal R&D teams and external inventors, e-Zassi helps accelerate the commercialization of new medical technologies. In July 2021, e-Zassi was acquired by Inova Software to create a more comprehensive innovation management suite for the biopharma industry.